Direct-to-consumer virtual health company Hims & Hers Health announced its plans to grow its Medical Advisory Board from five members to 15 members. The new members come from an array of medical specialties including urology, mental health and infectious disease. 

This news comes roughly a year after the company went public through a SPAC merger. Since listing on the New York Stock Exchange, the company has continued to expand into new specialties. 

The new board members include: OB/GYN Dr. Amy J. Voedisch, urologist Dr. Bertha Chen, urologist Dr. Lawrence Jenkins, urologist Dr. Lawrence Jenkins, urologist Dr. Stanton Honig, psychologist Stanley Althof, urologist Dr. Ranjith Ramasamy, infectious disease physician Dr. Jonathan Zenilman, pediatrician and epidemiologist Dr. Amanda D. Castel, and gastroenterologist Dr. Bhavesh B. Shah.

“As we work to build the new front door to healthcare, it’s fundamental that the experts who are helping us reflect the unique and broad perspectives of the communities we serve,” Hims & Hers cofounder and CEO Andrew Dudum said in a statement.

“We’re proud to welcome a diverse group of medical experts across a wide range of medical specialties and backgrounds who will help us develop new offerings, grow existing ones, and better serve our diverse customer base.”

Health analytics company K Health tapped Dr. Jennifer Peña to serve as its first chief medical officer. Peña previously served as a White House physician during the Obama and Trump administrations. She is an army veteran and currently serves as an assistant professor of medical education at the University of Virginia School of Medicine. 

At K Health, she will be working on its clinical strategy and helping health systems adopt and integrate K Health’s AI system. 

“Medicine is constantly changing, and the K Health technology is giving everyone access to truly up-to-date information, which means better patient outcomes and the elimination of billions of dollars in wasted medical costs,” Dr. Peña said in a statement.

“Remote clinical care is so much more than the method of connecting with patients. It is an overall experience and development of a relationship, and I want everyone in our country to see how K Health technology can drive better healthcare that we all deserve.”

New York-based digital therapeutics company Happify Health has named Megan Callahan its next chief operating officer. Callahan joins the team after serving as the president and general manager of Lyft Healthcare. She has also held roles at Change Healthcare and McKesson. 

Callahan’s new role will be focused on leading the company’s marketing and branding, as well as expanding the company’s partnerships. 

“We’re thrilled to welcome Megan Callahan to our team,” Tomer Ben-Kiki, cofounder and CEO at Happify Health, said in a statement. “As we move to our next phase of development, continue to scale, and look toward global distribution, Megan’s proven leadership in strategy, growth, and execution in the healthcare technology space will prove invaluable.

"Megan’s experience leading strategy and business development at Change Healthcare and McKesson have given her great insight into how best to develop and deploy platform-based healthcare solutions within partner ecosystems,” Ben-Kiki concluded.

Weight management company Found announced two new appointments: Dr. Rekha Kumar as chief medical officer and Dr. Acacia Parks as chief behavioral officer. 

This news comes just a few months after the company announced a $32 million funding round in the fall. 

Kumar is an endocrinologist at Cornell University and previously served as the Medical Director of the American Board of Obesity Medicine. Parks previously held the chief science officer position at Happify Health.